Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

  • This share is currently suspended. It was suspended at a price of 0.01
  • There is currently no data for VRS

Corporate Update

29 Jul 2025 07:00

RNS Number : 8890S
Versarien PLC
29 July 2025
 

 

 

29 July 2025

Versarien plc

("Versarien", the "Company" or the "Group")

Corporate Update

Versarien plc (AIM: VRS), the advanced engineering materials group, provides the following update on its restructuring process and financial position.

 

As stated in the Company's Interim Results, issued on 30 June 2025, the Board had appointed Leonard Curtis to undertake an accelerated sale of certain trade and assets of the Group's UK Technology companies (the "UK Technology Sale Process") whilst the Company focused on minimising the cash outflows from these operations. Other actions included seeking a strategic joint investment partner for the 3D Construction Printing ("3DCP") business and ceasing the trading activities of Versarien Korea Limited.

The UK Technology Sale Process has now concluded without a suitable offer being received by the Company. The Company therefore expects that Versarien Graphene Limited will shortly be placed into administration and Cambridge Graphene Limited and 2-DTech Limited will commence the process of voluntary liquidation. Versarien Korea Limited has now ceased all operations.

The ongoing Group will then consist of Versarien plc, Gnanomat SL and Total Carbide Limited (which the Company continues to market for sale) and will concentrate primarily on its hybrid nanomaterials and energy storage technologies.

These actions will conserve further cash and extend the Group's forecast runway through to the end of August 2025 to allow further time for the proposed, and previously announced, strategic investment to be closed, albeit there is no guarantee that it will do so. Should the strategic investment not be received the Board intends to appoint Leonard Curtis to conduct an accelerated sale process of the remaining Group assets.

Further announcements will be made in due course as appropriate.

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

 

+44 (0)20 3470 0470

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0)20 3934 6630

 

For further information please see: http://www.versarien.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAEXPAAXSEAA
Date   Source Headline
12th Dec 20249:59 amRNSHolding(s) in Company
11th Dec 20241:21 pmRNSHolding(s) in Company
4th Dec 20247:00 amRNS-RInvestor Presentation
27th Nov 20244:45 pmRNSHolding(s) in Company
26th Nov 20243:42 pmRNSHolding(s) in Company
21st Nov 202411:12 amRNSUpdate on Legal Claims
4th Nov 202412:07 pmRNSHolding(s) in Company
1st Nov 20247:00 amRNSTotal Voting Rights
31st Oct 202410:36 amRNSUpdate on Sale of Korean Assets
31st Oct 202410:14 amRNSHolding(s) in Company
18th Oct 202410:41 amRNSHolding(s) in Company
16th Oct 20247:00 amRNSPlacing to raise £450,000
4th Oct 20247:00 amRNSCorporate Update
30th Sep 20247:00 amRNSDisposal of AAC Cyroma Limited
14th Aug 20247:00 amRNS3D Construction Printing Contract
5th Aug 20241:16 pmRNSHolding(s) in Company
2nd Aug 202410:48 amRNSUpdate on Sale of Korean Assets
31st Jul 20242:30 pmRNSTotal Voting Rights
29th Jul 20241:47 pmRNSHolding(s) in Company
24th Jul 20247:00 amRNSPlacing to raise £550,000
18th Jul 20247:00 amRNSUpdate on Legal Claims
17th Jul 20247:00 amRNSConversion of Gnanomat Loan
6th Jun 20247:00 amRNSInterim Results for six months ended 31 March 2024
30th Apr 202411:59 amRNSResult of AGM
28th Mar 20247:00 amRNSAudited Results for year ended 30 September 2023
28th Mar 20247:00 amRNSTotal Voting Rights
20th Mar 20248:33 amRNSPlacing to raise £615,000
14th Mar 20247:00 amRNSSouth American Graphinks Agreements
11th Mar 20247:00 amRNSSale of Korean Assets and Licencing of IP
16th Feb 20242:22 pmRNSNotification of final results
7th Feb 20247:00 amRNSReceipt of Legal Claims
31st Jan 20247:00 amRNSTotal Voting Rights
23rd Jan 20244:53 pmRNSHolding(s) in Company
23rd Jan 20241:24 pmRNSHolding(s) in Company
19th Jan 20247:00 amRNSPlacing to raise £400,000
10th Jan 202411:29 amRNSResult of General Meeting
20th Dec 20237:00 amRNSCompany Update and Notice of General Meeting
30th Nov 20237:00 amRNSTotal Voting Rights
8th Nov 20237:00 amRNSPlacing to raise £454,822
30th Oct 202311:52 amRNSResult of General Meeting
30th Oct 20237:00 amRNSGeneral Meeting Statement
12th Oct 20237:00 amRNSNotice of General Meeting
2nd Oct 20237:00 amRNSCorporate Update
13th Sep 20237:00 amRNSTurnaround Strategy - Gnanomat Grant Award
31st Jul 20237:00 amRNSTotal Voting Rights
18th Jul 20234:31 pmRNSDirectorate Changes
14th Jul 20237:00 amRNSPlacing to raise £650,000
4th Jul 202310:54 amRNSResult of General Meeting
4th Jul 20237:00 amRNSGeneral Meeting Statement
15th Jun 20237:00 amRNSNotice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.